Brief: Timber Pharmaceuticals Provides Business Update And Announces First Quarter 2023 Financial Results
15/05/2023 22:34
Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
FIRST QUARTER 2023 FINANCIAL RESULTS
* TIMBER PHARMACEUTICALS INC - HAS NOW ENROLLED OVER 60% OF
PATIENTS FOR PIVOTAL TMB-001 PHASE 3 ASCEND CLINICAL TRIAL
* TIMBER PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $1.32
Source text for Eikon: ID:nGNX2vsQS1
Further company coverage: TMBR.A
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing